From Left: Dawn Walsh, Marketing Manager, Kernel Capital; Brendan Farrell, CEO, HiberGene Diagnostics and Kevin Healy, Senior Manager, Corporate Banking Ireland, Bank of Ireland.Cork Ireland, 20 April 2017:
Kernel Capital is delighted to confirm that the Bank of Ireland Kernel Capital Venture Funds investee company HiberGene Diagnostics has secured €6.7m Series B investment. The Bank of Ireland Kernel Capital Funds first invested in Hibergene in 2014 and have participated in this round which was led by Cantor Fitzgerald and includes investment from MedCaptain, and UK-based investors operating through the Enterprise Investment Scheme.
For more information please contact:
+353 (021) 4928974